Oncora AI

Oncora AI

SaaS data analytics for oncology care

Overview

Oncora AI provides data analytics software for cancer care through a SaaS platform that plugs into clinicians’ workflows. Its tools—Oncora Patient Care, Oncora Evidence, and Oncora Registry—help with clinical documentation, research, and cancer registries by extracting and analyzing data from patient records to support treatment decisions and reporting. The company differentiates itself with a focused oncology data approach, partnerships, and recognition in industry programs that emphasize data-driven care. Its goal is to improve cancer outcomes and speed clinical discoveries by making data insights accessible and actionable for oncologists and researchers.

About Oncora AI

Simplify's Rating
Why Oncora AI is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

1-10

Company Stage

Early VC

Total Funding

$5.6M

Headquarters

Philadelphia, Pennsylvania

Founded

N/A

Get referred to Oncora AI

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Registry AI launched at NCRA 2025 with 85% manual review reduction claims.
  • Kevin Yee became CTO in July 2025, strengthening AI infrastructure execution.
  • Oncora added Jeff Simon to its board in 2026, signaling radiation oncology credibility.

What critics are saying

  • Total funding sits at $5.6 million, limiting sales, product, and compliance capacity.
  • No disclosed financing since 2022 debt leaves Oncora undercapitalized against larger oncology vendors.
  • If hospital integrations stall, Varian and EHR incumbents can compress Oncora's relevance quickly.

What makes Oncora AI unique

  • Oncora AI focuses on oncology-specific AI, not generic healthcare software, since 2025.
  • Registry AI automates case finding, abstraction, and follow-up across Epic, MOSAIQ, and ARIA.
  • Varian invested in Oncora to accelerate radiation oncology software development in 2025.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$5.6M

Below

Industry Average

Funded Over

4 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Unlimited Paid Time Off

Parental Leave

Company News

PR Newswire
Nov 9th, 2023
Onco, Inc. Announces Strategic Partnership With Oncora Medical To Launch Data-Driven Software Automation To Enhance Patient Care And Oncology Data Management.

"The partnership between Oncora and ONCO will deliver meaningful improvements to cancer center workflows, while simultaneously laying the groundwork for precision medicine," states Oncora's CEO and Co-Founder, Dr. David Lindsay. .

IANS India Private Limited
Nov 9th, 2023
ONCO, Inc. Announces Strategic Partnership with Oncora Medical to Launch Data-Driven Software Automation to Enhance Patient Care and Oncology Data Management.

PHILADELPHIA and WALL, N.J. , Nov. 9, 2023 /PRNewswire-PRWeb/ -- ONCO Inc. (ONCO), a market leader in the oncology software and services space for over 40 years, is announcing a strategic alliance with Oncora Medical (Oncora), a startup company building an innovative patient care and research platform used by world-leading cancer centers.

Recently Posted Jobs

Sign up to get curated job recommendations

Oncora AI is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →